secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K
Filed at:   2024-09-06T23:59:59+00:00
Accession:  0001824293-24-000129
Event type: other_material
Sentiment:  negative
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

GRI Bio shareholders reject equity plan increase by 600K shares; director David Baker elected
--------------------------------------------------------------------------------

- David Baker elected Class I director with 61,134 for vs 40,091 against (155 abstain).
- Ratification of Sadler, Gibb & Associates as auditor passed: 285,641 for, 25,988 against.
- Proposal to issue shares underlying warrants (Nasdaq Rule 5635(d)) passed: 51,165 for, 47,971 against.
- Amendment to 2018 Equity Incentive Plan to add 600,000 shares failed: 31,556 for, 68,911 against.
- Quorum of 311,668 shares (42% of eligible) present at reconvened annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000182429324000129/0001824293-24-000129-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000182429324000129/val-20240906.htm
  HTML page:      https://secwatch.observer/filing/0001824293-24-000129

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer